Pivekimab, referred to as IBAT®, constitutes one unique genetically engineered cloned protein designed to directly target and inhibit IL-6, a critical molecule implicated in multiple pathogenic mechanisms underlying chronic conditions. This medicinal compound is produced by genetic engineering ge

Sutimlimab ( designated) this experimental agent is the highly selective antibody with the identification designation of that specific identifier. The drug works by selectively blocking the C5 protein, a crucial fragment of the antibody pathway . Such mechanism offers therapeutic potential for ma

Tralokinumab: Exploring the Promise of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a significant therapy for chronic dermatitis. This monoclonal antibody targets IL-13, a key cytokine involved in the progression of the disease . Clinical tria

L-Tryptophan is an vital amino acid that plays a significant role in various physiological processes within the human body. It serves as a precursor for the synthesis of several important neurotransmitters, including serotonin, which is known for its influence on mood, sleep, and appetite